Arctic Therapeutics closes an oversubscribed US$21.5 million financing round led by Pekron and Investcorp-backed Sanos Group. The funds will advance clinical development of pipeline assets AT-002 and AT-003.
PRIVATEOct 21, 2026
Amount Raised
$21.5 Million
Round Type
Venture
IcelandBiotechnologyHealth CareTherapeutics
Investors
LandvættirKaldbakurSanos GroupPekron
Description
Arctic Therapeutics announced the closing of a US$21.5 million financing round, which was oversubscribed due to strong investor demand. The round was led by Pekron, Sanos Group, Kaldbakur, and Landvættir. The proceeds will be used to further the clinical development of AT-002 and AT-003. This financing follows an earlier US$31 million Series A round that advanced the company's lead programs.
Who to call at Arctic Therapeutics, and when
A new round usually means Arctic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Arctic Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Arctic Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Arctic Therapeutics
Location
Iceland
About
Arctic Therapeutics is an Icelandic drug discovery and development startup focused on creating innovative treatments for dementia and other diseases. The company aims to develop groundbreaking therapies, particularly in the domain of amyloid protein management, to address significant unmet medical needs. Their lead projects, AT-001 and AT-004, are designed to treat familial dementia and other related conditions. Arctic Therapeutics is committed to transforming the landscape of healthcare through its scientific advancements.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arctic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.